These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 11438319

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Role of intercellular adhesion molecule-1 and E-selectin in the pathogenesis of ovarian hyperstimulation syndrome].
    Kovachev E, Kozovski I, Markova V, Gemer O, Cherneva S.
    Akush Ginekol (Sofiia); 2005; 44(4):26-31. PubMed ID: 16028375
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Interleukin-18 levels correlate with severe ovarian hyperstimulation syndrome.
    Barak V, Elchalal U, Edelstein M, Kalickman I, Lewin A, Abramov Y.
    Fertil Steril; 2004 Aug; 82(2):415-20. PubMed ID: 15302292
    [Abstract] [Full Text] [Related]

  • 5. Soluble endothelial and platelet selectins in serum and ascitic fluid of women with ovarian hyperstimulation syndrome.
    Daniel Y, Geva E, Amit A, Eshed-Englender T, Bar-Am A, Lessing JB.
    Am J Reprod Immunol; 2001 Mar; 45(3):154-60. PubMed ID: 11270640
    [Abstract] [Full Text] [Related]

  • 6. Levels of soluble vascular cell adhesion molecule-1 and soluble intercellular adhesion molecule-1 are increased in women with ovarian hyperstimulation syndrome.
    Daniel Y, Geva E, Amit A, Baram A, Englander T, Kupferminc MJ, Fait G, Lessing JB.
    Fertil Steril; 1999 May; 71(5):896-901. PubMed ID: 10231053
    [Abstract] [Full Text] [Related]

  • 7. Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian hyperstimulation for in vitro fertilization.
    Enskog A, Henriksson M, Unander M, Nilsson L, Brännström M.
    Fertil Steril; 1999 May; 71(5):808-14. PubMed ID: 10231037
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The kallikrein-kinin system, but not vascular endothelial growth factor, plays a role in the increased vascular permeability associated with ovarian hyperstimulation syndrome.
    Kobayashi H, Okada Y, Asahina T, Gotoh J, Terao T.
    J Mol Endocrinol; 1998 Jun; 20(3):363-74. PubMed ID: 9687159
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Soluble vascular endothelial-cadherin levels correlate with clinical and biological aspects of severe ovarian hyperstimulation syndrome.
    Villasante A, Pacheco A, Pau E, Ruiz A, Pellicer A, Garcia-Velasco JA.
    Hum Reprod; 2008 Mar; 23(3):662-7. PubMed ID: 18216038
    [Abstract] [Full Text] [Related]

  • 13. Increased angiotensin II in ascites during severe ovarian hyperstimulation syndrome: role of early pregnancy and ovarian gonadotropin stimulation.
    Delbaere A, Bergmann PJ, Gervy-Decoster C, Deschodt-Lanckman M, de Maertelaer V, Staroukine M, Camus M, Englert Y.
    Fertil Steril; 1997 Jun; 67(6):1038-45. PubMed ID: 9176441
    [Abstract] [Full Text] [Related]

  • 14. Comparative analysis of abdominal fluid cytokine levels in ovarian hyperstimulation syndrome (OHSS).
    Farkas B, Boldizsar F, Bohonyi N, Farkas N, Marczi S, Kovacs GL, Bodis J, Koppan M.
    J Ovarian Res; 2020 Mar 05; 13(1):25. PubMed ID: 32138790
    [Abstract] [Full Text] [Related]

  • 15. Concentration of soluble urokinase plasminogen activator receptor (suPAR) in the pre-ovulatory follicular fluid is associated with development of ovarian hyperstimulation syndrome during ovarian stimulation.
    Grynnerup AG, Toftager M, Zedeler A, Bogstad JW, Prætorius L, Grøndahl ML, Yding Andersen C, Sørensen S, Pinborg A, Løssl K.
    J Assist Reprod Genet; 2018 Dec 05; 35(12):2187-2193. PubMed ID: 30232642
    [Abstract] [Full Text] [Related]

  • 16. Ultrasound and hematological changes during early luteal phase in women at high risk for developing ovarian hyperstimulation syndrome.
    Lainas GT, Lainas TG, Venetis CA, Sfontouris IA, Zorzovilis IZ, Alexopoulou E, Tarlatzis BC, Kolibianakis EM.
    Ultrasound Obstet Gynecol; 2018 Jan 05; 51(1):126-133. PubMed ID: 29105961
    [Abstract] [Full Text] [Related]

  • 17. The pathogenesis of ovarian hyperstimulation syndrome: in vivo studies investigating the role of interleukin-1beta, interleukin-6, and vascular endothelial growth factor.
    Pellicer A, Albert C, Mercader A, Bonilla-Musoles F, Remohí J, Simón C.
    Fertil Steril; 1999 Mar 05; 71(3):482-9. PubMed ID: 10065786
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Coexistent hemoconcentration and hypoosmolality during superovulation and in severe ovarian hyperstimulation syndrome: a volume homeostasis paradox.
    Evbuomwan IO, Davison JM, Murdoch AP.
    Fertil Steril; 2000 Jul 05; 74(1):67-72. PubMed ID: 10899499
    [Abstract] [Full Text] [Related]

  • 20. C-reactive protein response is higher in early than in late ovarian hyperstimulation syndrome.
    Korhonen KV, Savolainen-Peltonen HM, Mikkola TS, Tiitinen AE, Unkila-Kallio LS.
    Eur J Obstet Gynecol Reprod Biol; 2016 Dec 05; 207():162-168. PubMed ID: 27865939
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.